Division of Nephrology, University Health Network, Toronto, Ontario, Canada.
Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada.
Clin J Am Soc Nephrol. 2024 Aug 1;19(8):1036-1044. doi: 10.2215/CJN.0000000000000499. Epub 2024 May 21.
There is a global interest in expanding home dialysis utilization among patients with ESKD. Home hemodialysis (HHD) is an appealing KRT option for this population because of its multiple clinical and quality of life benefits. Central to successful HHD is the establishment and maintenance of a functioning vascular access that serves as a patient's lifeline while on therapy. While the selection of a vascular access type is influenced by individual patient circumstances, the arteriovenous fistula is generally the preferred access method. Training patients to use their dialysis access requires attention to safety, risk management, and monitoring for complications to minimize adverse events and technique failure. Policies incorporating systematic frameworks for quality improvement and assurance, in conjunction with the measurement of metrics relating to vascular access, are tools that should be used by HHD programs to enhance the value of care delivered. In this perspective, we aim to describe what is currently known about the various vascular access options in HHD and to elucidate what needs to be taken into consideration in the selection and care of this access.
全球都有兴趣增加终末期肾病患者的居家透析利用率。对于这一人群,居家血液透析 (HHD) 是一种颇具吸引力的肾脏替代治疗选择,因为它具有多种临床和生活质量益处。成功进行 HHD 的关键在于建立和维持功能良好的血管通路,该通路在治疗期间是患者的生命线。虽然血管通路类型的选择受到患者个体情况的影响,但动静脉瘘通常是首选的通路方法。培训患者使用他们的透析通路需要注意安全、风险管理和并发症监测,以最大程度地减少不良事件和技术失败。将系统的质量改进和保证框架与与血管通路相关的指标测量相结合的政策,是 HHD 项目应该使用的工具,以提高所提供护理的价值。在本观点中,我们旨在描述 HHD 中各种血管通路选择的已知内容,并阐明在选择和护理这种通路时需要考虑的因素。